Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.860
+0.040 (1.42%)
Aug 28, 2026, 10:23 AM AEST

Australian Clinical Labs Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
24.7321.4426.1419.9626.37
Short-Term Investments
0.930.680.710.631.13
Cash & Short-Term Investments
25.6622.1226.8520.5927.51
Cash Growth
15.99%-17.60%30.40%-25.16%-24.19%
Accounts Receivable
64.7770.3375.6270.2687.47
Other Receivables
2.682.475.814.693.67
Receivables
67.4572.881.4374.9691.14
Inventory
14.2515.6216.8315.0920.09
Prepaid Expenses
5.589.528.55.324.14
Total Current Assets
112.93120.07133.6115.96142.87
Property, Plant & Equipment
293.72270.11281.7288.44310.2
Goodwill
159.11159.11158.68158.68158.68
Other Intangible Assets
5.866.16.266.496.72
Long-Term Deferred Tax Assets
19.0816.9710.748.239.42
Other Long-Term Assets
1.952.482.071.110.15
Total Assets
592.66574.84593.06578.91628.04

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
16.7220.5426.1917.9726.47
Accrued Expenses
46.3245.7544.6243.7946.33
Current Portion of Leases
108.4108.6104.71101.0994.77
Current Income Taxes Payable
0.378.543.240.015.62
Other Current Liabilities
38.0632.9828.9525.0851.98
Total Current Liabilities
209.87216.41207.7187.93225.16
Long-Term Debt
62.0541.9755.0665.7-
Long-Term Leases
166.95139.81149.13149.54167.61
Pension & Post-Retirement Benefits
3.983.73.43.082.71
Other Long-Term Liabilities
0.050.98---
Total Liabilities
442.9402.86415.3406.24395.49

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
758.94780.73797.98797.98797.98
Retained Earnings
32.8733.7526.2722.4583.43
Treasury Stock
-5.23-5.21-6.21-5.84-4.94
Comprehensive Income & Other
-637.06-637.92-640.5-642.18-644.02
Total Common Equity
149.52171.35177.53172.42232.44
Minority Interest
0.230.630.240.250.11
Shareholders' Equity
149.75171.98177.77172.67232.56
Total Liabilities & Equity
592.66574.84593.06578.91628.04

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
337.41290.38308.9316.32262.38
Net Cash (Debt)
-311.75-268.26-282.05-295.73-234.87
Net Cash Growth
-----
Net Cash Per Share
-1.62-1.34-1.41-1.47-1.17
Filing Date Shares Outstanding
185.05194.47200.24200.5200.81
Total Common Shares Outstanding
185.05194.47200.24200.5200.81
Working Capital
-96.94-96.34-74.1-71.97-82.29
Book Value Per Share
0.810.880.890.861.16
Tangible Book Value
-15.456.1512.587.2567.04
Tangible Book Value Per Share
-0.080.030.060.040.33
Machinery
122.44120.06115.36111.74106.27
Construction In Progress
1.080.70.211.693.35
Leasehold Improvements
59.3357.8656.1253.9651.73